[1]
|
Mahalingasivam, V., Booth, J., Sheaff, M. and Yaqoob, M. (2018) Nephrotic Syndrome in Adults. Acute Medicine, 17, 36-43.
|
[2]
|
Beck Jr., L.H., Bonegio, R.G., Lambeau, G., Beck, D.M., Powell, D.W., Cummins, T.D., Klein, J.B. and Salant, D.J. (2009) M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy. The New England Journal of Medicine, 361, 11-21. https://doi.org/10.1056/NEJMoa0810457
|
[3]
|
Beck Jr., L.H. and Salant, D.J. (2010) Membranous Nephropathy: Recent Travels and New Roads ahead. Kidney International, 77, 765-770. https://doi.org/10.1038/ki.2010.34
|
[4]
|
Ronco, P. and Debiec, H. (2005) Molecular Pathomechanisms of Membranous Nephropathy: From Heymann Nephritis to Alloimmunization. Journal of the American Society of Neph-rology, 16, 1205-1213.
https://doi.org/10.1681/ASN.2004121080
|
[5]
|
Dai, H., Zhang, H. and He, Y. (2015) Diagnostic Accuracy of PLA2R Autoantibodies and Glomerular Staining for the Differentiation of Idiopathic and Secondary Membranous Nephropathy: An Updated Meta-Analysis. Scientific Reports, 5, Article No. 8803. https://doi.org/10.1038/srep08803
|
[6]
|
Harza, M., Ismail, G., Mitroi, G., Gherghiceanu, M., Preda, A., Mircescu, G. and Sinescu, I. (2013) Histological Diagnosis and Risk of Renal Vein Thrombosis, and Other Thrombotic Complica-tions in Primitive Nephrotic Syndrome. Romanian Journal of Morphology and Embryology, 54, 555-560.
|
[7]
|
Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group (2021) KDIGO 2021 Clinical Practice Guide-line for the Management of Glomerular Diseases. Kidney International, 100, S1-S276.
|
[8]
|
Pang, L., Zhang, A.M., Li, H.X., Du, J.L., Jiao, L.L., Duan, N., Liu, Y. and Yu, D. (2017) Serum anti-PLA2R Antibody and Glomerular PLA2R Deposition in Chinese Patients with Membranous Nephropathy: A Cross-Sectional Study. Medicine, 96, e7218. https://doi.org/10.1097/MD.0000000000007218
|
[9]
|
Qin, W., Beck Jr., L.H., Zeng, C., Chen, Z., Li, S., Zuo, K., Salant, D.J. and Liu, Z. (2011) Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy. Journal of the American Society of Nephrology, 22, 1137-1143.
https://doi.org/10.1681/ASN.2010090967
|
[10]
|
Dou, Y., Zhang, L., Liu, D., Wang, C., Quan, S., Ma, S., Xiao, J., Cheng, G., Liu, Z. and Zhao, Z. (2016) The Accuracy of the Anti-Phospholipase A2 Receptor Antibody in the Diagnosis of Idiopathic Membranous Nephropathy: A Comparison of Different Cutoff Values as Measured by the ELISA Method. International Urology and Nephrology, 48, 845-849. https://doi.org/10.1007/s11255-016-1263-6
|
[11]
|
Senior, K., Burles, K., Wang, D., Grigat, D., Innes, G.D., Andruchow, J.E., Lang, E.S. and McRae, A.D. (2018) Age- Adjusted D-Dimer Thresholds in the Investigation of Suspected Pulmonary Embolism: A Retrospective Evaluation in Patients Ag-es 50 and Older Using Administrative Data. Canadian Journal of Emergency Medicine, 20, 725-731.
https://doi.org/10.1017/cem.2018.389
|
[12]
|
Barbour, S.J., Greenwald, A., Djurdjev, O., Levin, A., Hladunewich, M.A., Nachman, P.H., Hogan, S.L., Cattran, D.C. and Reich, H.N. (2012) Disease-Specific Risk of Venous Thrombo-embolic Events Is Increased in Idiopathic Glomerulonephritis. Kidney International, 81, 190-195. https://doi.org/10.1038/ki.2011.312
|
[13]
|
Li, S.J., Guo, J.Z., Zuo, K., Zhang, J., Wu, Y., Zhou, C.S., Lu, G.M. and Liu, Z.H. (2012) Thromboembolic Complications in Membranous Nephropathy Patients with Nephrotic Syndrome—A Prospective Study. Thrombosis Research, 130, 501-505. https://doi.org/10.1016/j.thromres.2012.04.015
|
[14]
|
Righini, M., Van Es, J., Den Exter, P.L., Roy, P.M., Verschuren, F., Ghuysen, A., Rutschmann, O.T., Sanchez, O., Jaffrelot, M., Trinh-Duc, A., et al. (2014) Age-Adjusted D-Dimer Cutoff Levels to Rule out Pulmonary Embolism: The ADJUST-PE Study. Journal of the American Medical Association, 311, 1117-1124.
https://doi.org/10.1001/jama.2014.2135
|
[15]
|
Hanasaki, K. (2004) Mammalian Phospholipase A2: Phospholipase A2 Receptor. Biological and Pharmaceutical Bulletin, 27, 1165-1167. https://doi.org/10.1248/bpb.27.1165
|
[16]
|
Tamaru, S., Mishina, H., Watanabe, Y., Watanabe, K., Fujioka, D., Takahashi, S., Suzuki, K., Nakamura, T., Obata, J.E., Kawabata, K., et al. (2013) Deficiency of Phospholipase A2 Re-ceptor Exacerbates Ovalbumin-Induced Lung Inflammation. The Journal of Immunology, 191, 1021-1028. https://doi.org/10.4049/jimmunol.1300738
|
[17]
|
Seitz-Polski, B., Dolla, G., Payre, C., Girard, C.A., Polidori, J., Zorzi, K., Birgy-Barelli, E., Jullien, P., Courivaud, C., Krummel, T., et al. (2016) Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. Journal of the American Society of Nephrology, 27, 1517-1533.
https://doi.org/10.1681/ASN.2014111061
|
[18]
|
Murakami, M., Nakatani, Y., Atsumi, G.I., Inoue, K. and Kudo, I. (2017) Regulatory Functions of Phospholipase A2. Critical Reviews in Immunology, 37, 127-195. https://doi.org/10.1615/CritRevImmunol.v37.i2-6.20
|
[19]
|
Lionaki, S., Derebail, V.K., Hogan, S.L., Barbour, S., Lee, T., Hladunewich, M., Greenwald, A., Hu, Y., Jennette, C.E., Jennette, J.C., et al. (2012) Venous Thromboembolism in Patients with Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 7, 43-51. https://doi.org/10.2215/CJN.04250511
|
[20]
|
Zou, H., Li, Y. and Xu, G. (2019) Management of Anticoagulation and Antiplatelet Therapy in Patients with Primary Membranous Nephropathy. BMC Nephrology, 20, Article No. 442. https://doi.org/10.1186/s12882-019-1637-y
|
[21]
|
Arghiani, M., Zamani, B.H., Nazemian, F., Samadi, S., Afshari-an, M.S., Habibzadeh, M., Eslami, S. and Sabbagh, M.G. (2021) A Cohort Study of Membranous Nephropathy, Primary or Secondary. BMC Nephrology, 22, Article No. 138.
https://doi.org/10.1186/s12882-021-02338-6
|